Ionix Medical, Inc. (formerly OncoStim, Inc.) is a privately held medical device company based in Minneapolis, Minnesota. Ionix Medical is developing the next generation of minimally-invasive prostate treatments. Our proprietary technology is being developed to ablate both benign and malignant tissues through the application of direct current.
Our goal is to develop a family of devices that will allow treatment that has been, until now, unattainable through present therapeutic methods and technologies. Our first product in development is the office-based NeufloTM System for treating benign prostatic hyperplasia (BPH) and will be followed by a system to treat prostate cancer.